The rapid onset of
the global COVID-19 pandemic has led to challenges
for accurately diagnosing the disease, including supply shortages
for sample collection, preservation, and purification. Currently,
most diagnostic tests require RNA extraction and detection by RT-PCR;
however, extraction is expensive and time-consuming and requires technical
expertise. With these challenges in mind, we report extraction-free,
multiplexed amplification of SARS-CoV-2 RNA from 246 clinical samples,
resulting in 86% sensitivity and 100% specificity. The multiplex RT-PCR
uses the CDC singleplex targets and has an LoD of 2 c/μL. We
also report on amplification using a range of master mixes in different
transport media. This work can help guide which combinations of reagents
will enable accurate results when availability of supplies changes
throughout the pandemic. Implementing these methods can reduce complexity
and cost, minimize reagent usage, expedite time to results, and increase
testing capacity.
Pathogen cell-free DNA (pcfDNA) in blood and urine is an attractive biomarker; however, the impact of preanalytical factors is not well understood. Blood and urine samples from healthy donors spiked with cfDNA from Mycobacterium tuberculosis, Salmonella enterica, Aspergillus fumigatus, and Epstein-Barr virus (EBV) and samples from tuberculosis patients were used to evaluate the impact of blood collection tube, urine preservative, processing delay, processing method, freezing and thawing, and sample volume on pcfDNA.
The rapid onset of the global COVID-19 pandemic has led to multiple challenges for accurately diagnosing the infection. One of the main bottlenecks for COVID-19 detection is reagent and material shortages for sample collection, preservation, and purification prior to testing. Currently, most authorized diagnostic tests require RNA extraction from patient samples and detection by reverse transcription polymerase chain reaction (RT-PCR). However, RNA purification is expensive, time consuming, and requires technical expertise to perform. Additionally, there have been reported shortages of the RNA purification kits needed for most tests. With these challenges in mind, we report on extraction-free amplification of SARS-CoV-2 RNA directly from patient samples. In addition, we have developed a multiplex RT-PCR using the CDC singleplex targets. This multiplex has a limit of detection of 2 copies/μL. We have demonstrated these improvements to the current diagnostic workflow, which reduce complexity and cost, minimize reagent usage, expedite time to results, and increase testing capacity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.